British Council BIRAX Ageing – Collaborative Research FundingClosing Date: 04/04/2022
Funding for joint UK-Israel projects that focus on researching aspects of ageing and age-related diseases, including cardiovascular disease, diabetes, neurodegenerative diseases and age-related frailty, multimorbidity and immunity.
BIRAX (Britain Israel Research and Academic Exchange Partnership) is a multi-million pound initiative of the British Council and the British Embassy in Israel that aims to foster and support world-leading collaborative research by scientists in Britain and Israel. The programme is managed by the British Council in Israel and is funded by the British Embassy and the Pears Foundation.
The BIRAX programme has two main strands – BIRAX Ageing and the Regenerative Medicine Initiative (RMI) – that work to strengthen academic research collaboration between the UK and Israel in their respective domains.
BIRAX Ageing focuses on aspects of ageing and its impact on human health. The programme offers funding for collaborative UK/Israel research projects, support for engagement opportunities (conferences, workshops and exchange opportunities) and mobility and travel grants for early career and senior researchers to take up fellowships, lectureships and attend symposia.
Under the biennial call for BIRAX Ageing research projects, proposals are invited for collaborative UK/Israel projects investigating the effect of ageing on human health, including preventive, disease modifying and regenerative medicine approaches to medical conditions and the ageing process.
Proposals are invited for experimental and observational studies – integrating diverse biological models and different system levels – that explore the relation of the ageing process with individual or multiple diseases and medical conditions, and their mitigation.
In particular, proposals are welcomed that advance precision medicine and big data in ageing research. Proposals should aim to identify innovative biomarkers, algorithms, computational and measurement techniques, and to promote advances in precision medicine that would allow the prevention or mitigation of age related conditions or harmful effects associated with ageing. Proposals that build on effective collaboration between basic and clinical research and big data and those facilitating the translation of basic research to clinical practice will be prioritised.
Research proposals can address issues using a broad range of biological organisational levels and scales, from molecular to cellular, tissues to organs and the entire organism and its environment. Multidisciplinary research plans based on synergising collaborations between the partnering researchers are recommended.
BIRAX Ageing also encourages the application of precision medicine and big data in ageing research, which should encompass precision diagnostics and personalised effects of treatments specifically for older subjects, preventive measures and predictive analytics for older populations. Research proposals that contain a central “omics” component (e.g. genomics, epigenomics, transcriptomics, proteomics, metabolomics) are encouraged.
Proposals submitted under the 2022 BIRAX Ageing Call for Proposals must support at least one of the following BIRAX Ageing priorities:
- Ageing and Immunity
- Age-related Multimorbidity
- Cardiovascular Disease
- How the Ageing Process Impacts on the Progression of Type 1 and Type 2 Diabetes
- Ageing Well with Diabetes
- Neurodegenerative Disease
- Age-related Frailty and Other Geriatric Syndromes
For the 2022 BIRAX Ageing Call for Proposals, projects may be co-funded by participating medical research charities from the UK and US, including the BrightFocus Foundation, British Heart Foundation, JDRF, Diabetes UK, MS Society, Alzheimer’s Research UK, Alzheimer’s Society and Parkinson’s UK.
|Funding body||British Council|
Biotechnology and Biology
|Fund or call||Fund|